INB will be holding a webinar with our Japanese distributor BM Equipment Co., Ltd to talk about epitope binning with FOPPR™. Join us!

Epitope binning immunoassays using Fiber Optic Particle Plasmon Resonance (FOPPR™) technology could be deployed in the development of new potential drug candidates. Furthermore, it could accommodate up to four mAbs in one experiment run, enabling this characterization process to be more time- and material-efficient for scientists.

This webinar will discusses how FOPPR™ is used to characterize closely related “bins” of mAbs targeting the same epitope of the target protein and how the selection process is used to develop assays. We also are pleased to take AnTaimmuBioMed as a real-world example to share how they use FOPPR™ to develop COVID-19 related therapeutic antibodies and diagnostic tools.

Speakers:
Tony Chung (CEO @Instant NanoBiosensors)
Aileen Sun (Technical Application Scientist @Instant NanoBiosensors)

Topic: Epitope Binning: A Critical Step in Antibody Development
Date: 16th Feb. 2022
Time: 10:00am JST (GMT+09)
Contact mail: hama@bmbio.co.jp, bd@instantnano.com

Register: https://us02web.zoom.us/webinar/register/WN_9wVT3TkUSIC9wjuEeeJH7Q